IMMEDIATE RELEASE FIXED-DOSE COMBINATION OF MEMANTINE AND DONEPEZIL

The present disclosure relates immediate release fixed-dosed combination pharmaceutical composition comprising the active pharmaceutical ingredients Memantine and Donepezil for the treatment of moderate to severe Alzheimer's disease. La présente invention concerne une composition pharmaceutique...

Full description

Saved in:
Bibliographic Details
Main Authors SILVA SERRA, João Pedro, PARDAL FILIPE, Augusto Eugénio, OLIVEIRA MACHUCO ESTEVENS, Maria Catarina, SILVA MARQUES DA COSTA, Ricardo Manuel
Format Patent
LanguageEnglish
French
Published 03.12.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates immediate release fixed-dosed combination pharmaceutical composition comprising the active pharmaceutical ingredients Memantine and Donepezil for the treatment of moderate to severe Alzheimer's disease. La présente invention concerne une composition pharmaceutique combinée à dose fixe et à libération immédiate comprenant les ingrédients pharmaceutiques actifs de la mémantine et du donépézil pour le traitement de la maladie d'Alzheimer modérée à grave.
Bibliography:Application Number: WO2020IB55137